| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/14/2007 | WO2007065663A1 Quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | WO2007065662A2 Trisubstituted quinazolinone derivatives as vanilloid antagonists |
| 06/14/2007 | WO2007065655A1 Disubstituted phenylpiperidines as modulators of cortical catecholaminergic neurotransmission |
| 06/14/2007 | WO2007065637A1 Orally administered antibiotics for the treatment of hemorrhoids |
| 06/14/2007 | WO2007065619A2 Foam wafer containing a polyvinyl alcohol-polyethyleneglycol-graft copolymer |
| 06/14/2007 | WO2007065595A2 Xanthine derivatives, processes for preparing them and their uses |
| 06/14/2007 | WO2007065594A2 Unsaturated fatty acids as thrombin inhibitors |
| 06/14/2007 | WO2007065559A1 Zolpidem tablets |
| 06/14/2007 | WO2007065518A1 Pyridiazinone derivatives for tumour treatment |
| 06/14/2007 | WO2007065451A1 Means for preventing and treating rhinitis of different ethiology, method for the production thereof, a pharmaceutical composition based thereon and a preventing and treating method |
| 06/14/2007 | WO2007065450A1 Means for preventing and treating conjunctivitis of different ethiology (variants) and a method for the use thereof |
| 06/14/2007 | WO2007065449A1 Pyrimidine derivatives and their use as kcnq potassium channels openers |
| 06/14/2007 | WO2007065448A1 Stable solid formulation of sertindole |
| 06/14/2007 | WO2007065437A2 Modulation of the p2y2 receptor pathway |
| 06/14/2007 | WO2007065428A1 Low flexural strength transdermal tobacco alkaloid patch |
| 06/14/2007 | WO2007065427A1 Transdermal tobacco alkaloid patch |
| 06/14/2007 | WO2007065303A1 Transdermal patch containing isosorbide dinitrate and bisoprolol |
| 06/14/2007 | WO2007065289A2 4-oxo-(iso)tretinoin for the topical treatment of severe dermatological disorders |
| 06/14/2007 | WO2007065288A2 Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
| 06/14/2007 | WO2007065281A1 Quaternary 3 -amido, n-methylpyridinium salts as anti -inflammatory agents |
| 06/14/2007 | WO2007065273A1 Mucopolysaccharidosis (mps) diagnostic methods, systems, kits and assays associated therewith |
| 06/14/2007 | WO2007065261A1 Plasminogen activator inhibitor-1 inhibitors |
| 06/14/2007 | WO2007065256A1 Novel spiropiperidine compounds and methods for the modulation of chemokine receptor activity |
| 06/14/2007 | WO2007065231A2 Azacytosine derivatives useful as antiviral agents |
| 06/14/2007 | WO2007050784A3 Fixed ratio drug combination treatments for solid tumors |
| 06/14/2007 | WO2007050721A3 Heterocyclic aspartyl protease inhibitors |
| 06/14/2007 | WO2007050375A3 Piperazine derivatives useful as ccr5 antagonists |
| 06/14/2007 | WO2007048848A3 V-atpase inhibitors for use in the treatment of septic shock |
| 06/14/2007 | WO2007048847A3 Indole and azaindole derivatives for the treatment of inflammatory and autoimmune diseases |
| 06/14/2007 | WO2007048801A3 Sexual desire enhancing medicaments comprising benzimidazolone derivatives |
| 06/14/2007 | WO2007048352B1 Pharmaceutical composition and method for regenerating myofibers in the treatment of muscle injuries |
| 06/14/2007 | WO2007048244A3 Small interfering ribonucleic acid duplexes comprising arabinose modified nucleotides |
| 06/14/2007 | WO2007048223A3 A gastric retention drug delivery system |
| 06/14/2007 | WO2007048046A9 Sirna silencing of filovirus gene expression |
| 06/14/2007 | WO2007047512A3 Inhibition of pax2 by defb1 induction as a therapy for cancer |
| 06/14/2007 | WO2007047401A3 A1 adenosine receptor agonists |
| 06/14/2007 | WO2007047253A8 Pharmaceutical formulations of cyclodextrins and antifungal azole compounds |
| 06/14/2007 | WO2007046122A3 Ozonised oil, process for the preparation and use thereof in medical field |
| 06/14/2007 | WO2007045705A3 Compounds for the treatment of auricular fibrillation |
| 06/14/2007 | WO2007045639A8 Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| 06/14/2007 | WO2007044950A3 Crystalline forms of docetaxel and processes for their preparation |
| 06/14/2007 | WO2007044927A3 6, 11-bridged tricyclic macrolides |
| 06/14/2007 | WO2007044560A3 Modulators of atp-binding cassette transporters |
| 06/14/2007 | WO2007044407A3 Pyrazolo (1 , 5a) pyrimidines as protein kinase inhibitors |
| 06/14/2007 | WO2007044348A8 Anti-infective hygiene products based on cellulose acetate phthalate |
| 06/14/2007 | WO2007044050A3 1h-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same |
| 06/14/2007 | WO2007043294A9 Visceral fat accumulation inhibitor |
| 06/14/2007 | WO2007042035A3 Combination therapy with fumaric acid esters for the treatment of autoimmune and/or inflammatory disorders |
| 06/14/2007 | WO2007040840A3 Aminodiazepines as toll-like receptor modulators |
| 06/14/2007 | WO2007039294A3 Gelling compositions and methods |
| 06/14/2007 | WO2007039111A3 Novel multi-cyclic compounds and their use |
| 06/14/2007 | WO2007038675A3 Pharmaceutical compositions for treating or preventing migraines |
| 06/14/2007 | WO2007036363A8 Compositions containing butyric acid ester of carbohydrates and carbohydrate polyols |
| 06/14/2007 | WO2007035573A3 Anesthesia induction and maintenance drug |
| 06/14/2007 | WO2007035448A3 Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses |
| 06/14/2007 | WO2007035395A9 Therapeutic compositions comprising chorionic gonadotropins and hmg coa reductase inhibitors |
| 06/14/2007 | WO2007035372A3 Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor |
| 06/14/2007 | WO2007035313A3 Sachet formulation for amine polymers |
| 06/14/2007 | WO2007034510B1 Derivatives of 4,6-disubstituted 1,2,4-triazolo-1,3,4-thiadiazole, a process and uses thereof |
| 06/14/2007 | WO2007034210A3 Deglycosylated anti-muc-1 antibodies and uses thereof |
| 06/14/2007 | WO2007034188A3 Chemo-immunotherapy method |
| 06/14/2007 | WO2007032019A3 Process for preparing valsartan |
| 06/14/2007 | WO2007030691A3 Antisense antiviral compound and method for treating picornavirus infection |
| 06/14/2007 | WO2007030582A3 Acyclic ikur inhibitors |
| 06/14/2007 | WO2007030576A3 Antisense antiviral compound and method for treating picornavirus infection |
| 06/14/2007 | WO2007030460A3 Hydrophobic polysaccharide derivatives |
| 06/14/2007 | WO2007029258A3 Use of lipid conjugates in the treatment of infection |
| 06/14/2007 | WO2007028047A3 Immunological uses of immunodulatory compounds for vaccine and anti-infections disease therapy |
| 06/14/2007 | WO2007026028A3 Pharmaceutical composition comprising an iron chelator |
| 06/14/2007 | WO2007022470A3 Methods and compositions for treating neurological disease |
| 06/14/2007 | WO2007021839A3 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors |
| 06/14/2007 | WO2007017497A3 Staurosporine derivatives for treating non-small cell lung cancer |
| 06/14/2007 | WO2007016419A3 Methods and compositions for reducing skin damage |
| 06/14/2007 | WO2007010014A3 Compositions for treatment of systemic mastocytosis |
| 06/14/2007 | WO2007007903A3 Carboxamide compound and use of the same |
| 06/14/2007 | WO2007005455A3 Improved process for preparing (disubstitutedpropenyl) phenylalkyl substituted heterocycles |
| 06/14/2007 | WO2007005453A3 Compositions for treating or preventing obesity and insulin resistance disorders |
| 06/14/2007 | WO2007004685A3 Compositions for ameliorating a reduced higher brain function resulting from organic brain lesions |
| 06/14/2007 | WO2007002462A3 Crystalline forms of mc4r agonist and process for synthesis |
| 06/14/2007 | WO2006138431A3 Methods and pharmaceutical formulations for increasing bioavailability |
| 06/14/2007 | WO2006135689A3 Nanoparticulate ebastine formulations |
| 06/14/2007 | WO2006135413A3 Encapsidation system for production of recombinant virus-like particles |
| 06/14/2007 | WO2006133022A3 Compositions and methods for decreasing microrna expression for the treatment of neoplasia |
| 06/14/2007 | WO2006132950A3 Therapeutic polymers and methods of use |
| 06/14/2007 | WO2006124699A3 Blockade of pin1 prevents cytokine production by activated immune cells |
| 06/14/2007 | WO2006123246A3 Methods for identifying chemotherapeutic resistance in non-hematopoietic tumors |
| 06/14/2007 | WO2006123183A3 Sulphone derivatives for treatment of cancer |
| 06/14/2007 | WO2006119779A3 A pharmaceutical composition comprising an aldosterone antagonist in form of solid solution |
| 06/14/2007 | WO2006118966A3 Phospholipid formulations and uses thereof in lung disease detection and treatment |
| 06/14/2007 | WO2006113937A3 Method for treating apathy syndrome |
| 06/14/2007 | WO2006113531A3 Combination formulation |
| 06/14/2007 | WO2006109192A3 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 06/14/2007 | WO2006108582A3 Human marker genes and agents for diagnosis, treatment and prophylaxis of cardiovascular disorders and artherosclerosis |
| 06/14/2007 | WO2006104897A3 Cytoskeletal active compounds, composition and use |
| 06/14/2007 | WO2006100213A8 Composition comprising a combined thromboxane receptor antagonist and thromboxane synthase inhibitor and a cox-2 inhibitor |
| 06/14/2007 | WO2006099379A3 Benzazole derivatives, compositions, and methods of use as b-secretase inhibitors |
| 06/14/2007 | WO2006085334A3 Novel betulinic acid derivatives a-ring-condensed to a heterocyclic group |
| 06/14/2007 | WO2006082063A3 Cpg-odn (oligodeoxynucleotides) with stem-loop and flanking sequences without cpg-motifs for the treatment of skin diseases |
| 06/14/2007 | WO2006078629A3 In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair |
| 06/14/2007 | WO2006074265A3 Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders |